Physician profile
Michael E Zavaski
NPI 1427491919
$22,780.66
in general payments reported to CMS, 2019-2025
15 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $3,962 · 2021: $10K · 2022: $4,110 · 2023: $3,430 · 2024: $266 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,100 · Food and Beverage: $909 · Travel and Lodging: $99.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,100.00 |
| Food and Beverage | $909.20 |
| Travel and Lodging | $99.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21,704.10 | 2020-2023 | Moses 550 D\F\L |
| Ferring Pharmaceuticals INC. | $204.76 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $192.25 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $162.10 | 2022-2025 | |
| Accord Healthcare, INC. | $119.16 | 2024-2025 | |
| Olympus America INC. | $108.20 | 2019 | |
| Abbvie INC. | $88.42 | 2019-2024 | Botox |
| Endo USA, INC. | $45.35 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $32.72 | 2023 | Urolift |
| Laborie Medical Technologies Corp. | $31.32 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $21.23 | 2024 | Aveed, Xiaflex |
| Calyxo, INC. | $20.74 | 2025 | Cvac Aspiration System |
| Immunitybio, INC. | $19.35 | 2025 | |
| Baudax Bio INC. | $16.45 | 2020 | |
| Axonics, INC. | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zavaski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.